Position in RPRX
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$526,086
+$135,050 QoQ
Shares Held
10,967
+8.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bleakley Financial Group, LLC holds $16,625,065 across 16 Biotechnology names. RPRX ranks #7 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
17,226 | $7,692,098 | |
| 2 | ANAB |
Anaptysbio, Inc
|
43,120 | $1,594,288 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
12,802 | $1,349,330 | |
| 4 | IBRX |
ImmunityBio, Inc.
|
163,572 | $1,254,597 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
14,316 | $1,074,988 | |
| 6 | BCAX |
Bicara Therapeutics Inc.
|
29,331 | $583,393 | |
| 7 | RPRX |
Royalty Pharma plc
This page
|
10,967 | $526,086 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
11,628 | $386,282 |
All Filings in RPRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $526,086 | 10,967 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $391,036 | 10,120 | Shares | Sole | 2026-02-09 | |
| 2025-06-30 | $387,790 | 10,763 | Shares | Sole | 2025-07-30 | |
| No filing history on record for this holder in this stock. | ||||||